Kyle Musgrove has nearly 20 years of experience as an intellectual property litigator. He has served as lead trial counsel and argued appeals at the United States Court of Appeals for the Federal Circuit.

Kyle’s career primarily has been devoted to patent litigation under the Hatch-Waxman Act. A number of his cases have involved drug products with sales exceeding $1 billion per year. Despite the high stakes, Kyle has successfully obtained judgments invalidating and/or holding non-infringed the asserted claims of patents alleged to cover those products. In some instances, his strategic approach to litigation has facilitated favorable settlements for his clients while avoiding the uncertainties and expense associated with protracted litigation.

In addition to his Hatch-Waxman practice, Kyle has litigated cases in a variety of technologies including paper and pulp bleaching, optics, cervical collars, medical devices and imaging, nutritional supplements, vaccines and methods of drug delivery. His practice includes the representation of both patentees and alleged infringers. He has practiced before the United States Court of Appeals for the Federal Circuit, various district courts, and the International Trade Commission.

Further aspects of Kyle's practice include conducting interference proceedings, counseling clients regarding possible infringement or invalidity issues, managing patent prosecution portfolios for major international clients and transactional work relating to intellectual property.

Kyle previously authored an annually updated chapter relating to the intersection of the patent and antitrust laws for Aspen Publishing, and he has participated as litigation counsel in cases alleging antitrust violations due to "sham" litigation brought by patentees. Additionally, he was recognized by LMG Life Sciences as a "Life Science Star" since 2012.

Mr. Musgrove was a partner at a national intellectual property boutique prior to joining Haynes and Boone.